Santos da Silva Jorge 4
4 · MoonLake Immunotherapeutics · Filed Jan 9, 2026
Insider Transaction Report
Form 4
Santos da Silva Jorge
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2026-01-07+520,342→ 520,342 totalExercise: $11.29Exp: 2036-01-07→ Class A ordinary shares, par value $0.0001 per share (520,342 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 520,342 of the Issuer's Class A ordinary shares, vesting in four equal annual installments on January 7, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.